Psychiatric Risk in CSU May Be More Limited Than Previously Thought

Patients with chronic spontaneous urticaria (CSU) may not face the broad risk of developing psychiatric disease suggested by previous observational studies, according to a large retrospective cohort study published in Acta Derm Venereol. While investigators observed a modest increase in stress-related and adjustment disorders, they found no consistent increase in incident depression, schizophrenia, or suicide-related outcomes following a CSU diagnosis.

The findings add important context to the growing understanding of CSU's overall disease burden which Dermatology Times has previously reported significantly affects patients' quality of life and mental well-being through persistent itch, wheals, and unpredictable flares. Rather than suggesting a broad increase in psychiatric disease, the study indicates the relationship may be more nuanced than previously appreciated.¹

Large Cohort Examined Incident Psychiatric Disease

Investigators analyzed electronic health record data from the TriNetX US Collaborative Network, identifying 98,785 adults with newly diagnosed CSU and no prior psychiatric diagnosis. Patients were matched 1:1 with non-CSU controls and followed for up to 3 years to evaluate incident depression, stress-related and adjustment disorders, schizophrenia, and suicide-related outcomes.¹

Compared with matched controls, patients with CSU experienced a modest but statistically significant increase in stress-related and adjustment disorders (hazard ratio [HR], 1.15; 95% CI, 1.09-1.22). The association remained consistent across five prespecified sensitivity analyses. In contrast, investigators found no consistent increase in incident depression, schizophrenia, or suicide-related outcomes. The investigators emphasized that these findings should not be interpreted as evidence against psychiatric screening but rather suggest that any increased psychiatric risk appears to be concentrated among stress-related conditions.¹

Why the Findings Differ From Previous Studies

The authors suggested that differences in study design may explain why their findings were more conservative than earlier reports. Unlike many previous investigations, the current study excluded patients with documented psychiatric disease before CSU diagnosis and incorporated multiple sensitivity analyses to reduce reverse causation and surveillance bias.

The investigators proposed that "much of the previously reported comorbidity reflects pre-existing psychiatric vulnerability rather than a consequence of CSU itself," suggesting differences in study design may account for conflicting findings across the literature.¹

Potential Implications for Clinical Practice

Although the findings do not diminish the psychosocial burden experienced by many patients with CSU, they suggest clinicians may benefit from distinguishing between pre-existing psychiatric comorbidity and psychiatric disease that develops after diagnosis. Consistent with this interpretation, the authors wrote that routine psychodermatology referral "based on CSU diagnosis alone" is not supported and that multidisciplinary care decisions "should be guided by the presence of clinical symptoms."¹

Study Limitations

The investigators acknowledged several limitations, including reliance on electronic health record coding, the potential for residual confounding, and the inability to establish causality. Anxiety disorders were intentionally excluded from the primary analysis because of concerns regarding surveillance bias and symptom overlap with CSU-related distress. Additionally, the findings may not be generalizable beyond health systems represented in the TriNetX network.¹

What This Means for Clinicians

Although the findings are unlikely to immediately change clinical practice, they may help refine conversations surrounding psychiatric risk in patients with CSU. Rather than assuming a broadly increased risk of incident psychiatric disease, dermatologists may consider focusing screening and referral decisions on patients with clinically significant psychological symptoms, particularly those experiencing stress-related distress, while continuing to recognize the substantial quality-of-life burden associated with CSU.

References:

1. Curman P, Olbrich H, Kridin K, Thaçi D, Ludwig RJ. Psychiatric risk in chronic spontaneous urticaria: a retrospective cohort study. Acta Derm Venereol. 2026;106. doi:10.2340/actadv.v106.adv-2026-0643.